Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.30, Iss.2, 2012-04, pp. : 518-523

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potent anti-tumor activity of a macrocycle-quinoxalinone class pan-Cdk inhibitor in vitro and in vivo

By Hirai Hiroshi

Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. : 534-543

Springer Publishing Company

Access to resources Recommend Favorite

Formation and Anti-Tumor Activity of Uncommon In Vitro and In Vivo Metabolites of CPI-613, a Novel Anti-Tumor Compound That Selectively Alters Tumor Energy Metabolism

Drug Metabolism Letters, Vol. 5, Iss. 3, 2011-08 ,pp. : 163-182

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Kinase Inhibitors

Current Medicinal Chemistry, Vol. 22, Iss. 6, 2015-02 ,pp. : 695-712

Bentham Science Publishers

Access to resources Recommend Favorite

ZD6474, a Small Molecule Tyrosine Kinase Inhibitor, Potentiates the Anti-Tumor and Anti-Metastasis Effects of Radiation for Human Nasopharyngeal Carcinoma

Current Cancer Drug Targets, Vol. 10, Iss. 6, 2010-01 ,pp. : 611-622

Bentham Science Publishers

Access to resources Recommend Favorite

Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer

By Fan Alice C O'Rourke Jennifer J Praharaj Dave R Felsher Dean W

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. : 1495-1509

Informa Healthcare

Access to resources Recommend Favorite